JT
Jashini Tyni Mallidi
About Jashini Tyni Mallidi
Data last updated:
Jashini Tyni Mallidi has 4 years in corporate governance. Holds Director role. Currently with 3 companies, including Yalama International Pharmaceutical Private Limited and Lucentra Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lucentra Private Limited U62099TS2026PTC209257 | Director | 06 Jan 2026 | 2026 | – | Active |
| Windfall International Super Speciality Hospitals Private Limited U86100TS2023PTC174056 | Director | 13 Jun 2023 | 2023 | – | Active |
| Yalama International Pharmaceutical Private Limited U24304AP2021PTC119732 | Director | 13 Oct 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jashini Tyni Mallidi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jashini Tyni Mallidi
Jashini Tyni Mallidi has 4 years in corporate governance. Holds Director role. Currently with 3 companies, including Yalama International Pharmaceutical Private Limited and Lucentra Private Limited. Engaged in General Business. Contributes to corporate operations.
Jashini Tyni Mallidi is associated with 3 companies as Director, including Lucentra Private Limited, Windfall International Super Speciality Hospitals Private Limited, Yalama International Pharmaceutical Private Limited.
Jashini Tyni Mallidi has expertise in General Business.
Jashini Tyni Mallidi has 4 years in corporate governance.
Jashini Tyni Mallidi currently holds positions at 3 companies: Lucentra Private Limited, Windfall International Super Speciality Hospitals Private Limited, Yalama International Pharmaceutical Private Limited.